Dr. Agarwal's Health Care Limited (BOM:544350)
India · Delayed Price · Currency is INR 488.15
+4.30 (0.89%)
At close: Oct 6, 2026
Dr. Agarwal's Health Care Revenue
Dr. Agarwal's Health Care had revenue of 6.14B INR in the quarter ending June 30, 2026, with 25.97% growth. This brings the company's revenue in the last twelve months to 22.07B, up 22.94% year-over-year. In the fiscal year ending March 31, 2026, Dr. Agarwal's Health Care had annual revenue of 20.80B with 21.57% growth.
Revenue (ttm)
22.07B
Revenue Growth
+22.94%
P/S Ratio
6.99
Revenue / Employee
n/a
Employees
n/a
Market Cap
154.34B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 20.80B | 3.69B | 21.57% |
| Mar 31, 2025 | 17.11B | 3.79B | 28.44% |
| Mar 31, 2024 | 13.32B | 3.14B | 30.86% |
| Mar 31, 2023 | 10.18B | 3.22B | 46.25% |
| Mar 31, 2022 | 6.96B | 2.25B | 47.73% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Tata Chemicals | 151.20B |
| Vardhman Textiles | 101.86B |
| Jubilant Pharmova | 86.08B |
| Punjab & Sind Bank | 48.54B |
| Zydus Wellness | 45.37B |
| Nava Limited | 43.09B |
| Usha Martin | 38.37B |
| AstraZeneca Pharma India | 24.32B |